Overview
- 168 inspections across 156 sites are on record.
- 149 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-01.
At a glance
Inspections
168
Sites
156
Observations
149
Career since
Jul 2015
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Eduardo E. Rodriguez-Araya, MD | 1 May 2026 | Human Drugs | On file |
| Bradly S. Goodman, M.D. | 13 Mar 2026 | Medical Devices & Rad Health | |
| Ziv J. Haskal, MD | 27 Feb 2026 | Medical Devices & Rad Health | On file |
| BioReliance Corporation | 29 Jan 2026 | Human Drugs | On file |
| Novocure GmbH | 19 Dec 2025 | Medical Devices & Rad Health |
Sites inspected
Eduardo E. Rodriguez-Araya, MDNew Orleans, United States1 insp.
Bradly S. Goodman, M.D.Birmingham, United States1 insp.
Ziv J. Haskal, MDCharlottesville, United States1 insp.
BioReliance CorporationRockville, United States1 insp.
Novocure GmbHBaar, Switzerland1 insp.
Co-investigators
Investigators who share inspections with this person.
Young M Yoon14 shared
Melanie N Daniels12 shared
John Dan9 shared
Lucilla Facchin8 shared
Ellen A Humphrey5 shared
Cheryl A Grandinetti5 shared
Brittany L Carpenter4 shared
Tiki Dixon4 shared
Lee Hong Pai Scherf3 shared
Anne E Johnson3 shared
Full investigator report
Get the verbatim findings behind David L Chon's 149 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site